Movano health provides progress update on eviemed regulatory filing

Company continues to work with fda to bring this pioneering healthcare product to market pleasanton, calif. , aug. 5, 2024 /prnewswire/ --  movano health  (nasdaq:  move ) plans to meet with the fda in mid-august, as part of the company's ongoing process to secure a 510(k) clearance for the eviemed ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging.
MOVE Ratings Summary
MOVE Quant Ranking